Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • BI 847325 - Neoplasms
    Clinical Study Number 1287.1
    Study Indication Neoplasms
    Product BI 847325
    Generic Name BI 847325
    Lab Code
    Clinical Phase Ia/Ib
    Study Title

    An open-label, uncontrolled Phase Ia/Ib study of two dosing schedules of BI 847325 orally administered once a day in patients with advanced solid tumours, with repeated administration in patients with clinical benefit

    Study Document
    Trial synopsis 1287.1 english